Mothaffar F. Rimawi MD

Clinical Trials

• Neoadjuvant Herceptin in Patients With Breast Cancer Start of enrollment: 2001 Oct 01

  Terminated

  Phase 2

• Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer Start of enrollment: 2003 Jan 01

  Terminated

  Phase 2

• Neoadjuvant GW572016 to Treat Breast Cancer Start of enrollment: 2004 Aug 01

  Completed

  Phase 2

• Nexium Study To Suppress Nausea During Chemotherapy Start of enrollment: 2005 Aug 01

  Terminated

  Phase 3

• Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer Start of enrollment: 2002 Jan 01

  Terminated

  Phase 2

• Biologic Correlative Taxotere/AC Start of enrollment: 2002 Apr 01

  Completed

  Phase 2

• Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients Start of enrollment: 2004 Sep 01

  Completed

  Phase 2

• Lapatinib and Trastuzumab With or Without Endocrine Therapy Start of enrollment: 2008 May 01

  Completed

  Phase 2

• Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer Start of enrollment: 2007 Dec 01

  Completed

  Phase 2

• Brain Mets - Capecitabine Plus Sunitinib and WBRT Start of enrollment: 2009 Feb 01

  Terminated

  Phase 2

• Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10

  ACTIVE_NOT_RECRUITING

  PHASE3

• Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients Start of enrollment: 2008 Dec 01

  Terminated

  Phase 2

• Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy

  ACTIVE_NOT_RECRUITING

  PHASE2

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15

  ACTIVE_NOT_RECRUITING

  PHASE3

• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06

  ACTIVE_NOT_RECRUITING

  PHASE3

• A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer Start of enrollment: 2012 Aug 01

  Completed

  Phase 2

• Scalp Cooling to Prevent Chemo-induced Hair Loss Start of enrollment: 2014 May 15

  Active, not recruiting

  Not Applicable

• High Dose Vitamin D vs Standard Dose Vitamin D Study Start of enrollment: 2013 Dec 01

  Terminated

  Phase 2

• Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15

  ACTIVE_NOT_RECRUITING

  PHASE3

• CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer Start of enrollment: 2014 Jun 01

  Terminated

  Phase 1

• A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22

  ACTIVE_NOT_RECRUITING

  PHASE3

• Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer Start of enrollment: 2015 Jun 01

  Terminated

  Phase 1, Phase 2

• TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer Start of enrollment: 2017 Oct 10

  ACTIVE_NOT_RECRUITING

  PHASE2

• ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer Start of enrollment: 2019 May 25

  COMPLETED

  PHASE1, PHASE2

• Join now to see all